Damon DeSantis - 15 Apr 2026 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: INBP
Reported as of: 15 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Apr 2026, 11:21:53 UTC
Prior SEC filing: 25 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Damon DeSantis

Key filing fact

Damon DeSantis filed Form 4 for INTEGRATED BIOPHARMA INC (INBP) on 17 Apr 2026.

Key facts

This page summarizes Damon DeSantis's Form 4 filing for INTEGRATED BIOPHARMA INC (INBP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Apr 2026, 11:21.

Change

Previous filing in this sequence was filed on 25 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001889279 Primary reporting owner

DeSantis Damon

Relationship: Director, 10%+ Owner
Address: 109 SE 5TH AVENUE, SECOND FLOOR, DELRAY BEACH
Signature: /s/ Damon DeSantis
Signature date: 17 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBP transaction

Common Stock

Gift

Transaction value
Shares: +8,966,547
Change %: +586%
Price: $0.000000^*
Shares after: 10,497,641
Date: 15 Apr 2026
Ownership: By CDDS 2.0, LLC
Footnotes: F1

INBP transaction

Common Stock

Gift

Transaction value
Shares: +2,235,417
Change %: +21%
Price: $0.000000^*
Shares after: 12,733,058
Date: 15 Apr 2026
Ownership: By CDDS 2.0, LLC
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Footnote F2

Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.